Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration
- 1 September 2016
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 92, 287-297
Abstract
No abstract availableKeywords
Funding Information
- General Foundation of the University of Alcalá
- Complutense University of Madrid (UCM920415 (GR3/14))
This publication has 53 references indexed in Scilit:
- Novel biodegradable polyesteramide microspheres for controlled drug delivery in OphthalmologyJournal of Controlled Release, 2015
- Using Current Data to Define New Approach in Age Related Macular Degeneration: Need to Accelerate Translational ResearchCurrent Genomics, 2014
- Stress, Inflammation, and Defense of HomeostasisMolecular Cell, 2014
- Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedureJournal of Controlled Release, 2011
- Effect of Gold Nanoparticle Aggregation on Cell Uptake and ToxicityACS Nano, 2011
- Using Polymer Chemistry to Modulate the Delivery of Neurotrophic Factors from Degradable Microspheres: Delivery of BDNFPharmaceutical Research, 2009
- Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasoneExperimental Eye Research, 2009
- The Anti-Apoptotic Activity of Albumin for Endothelium Is Mediated by a Partially Cryptic Protein Domain and Reduced by Inhibitors of G-Coupled Protein and PI-3 Kinase, but Is Independent of Radical Scavenging or Bound LipidJournal of Vascular Research, 2007
- Poly(lactic-co-glycolic acid) microspheres as a potential bulking agent for urological injection therapy: Preliminary resultsJournal of Biomedical Materials Research, 2004
- A Novel in Vitro Delivery System for Assessing the Biological Integrity of Protein upon Release from PLGA MicrospheresPharmaceutical Research, 2002